文献速递妇科产科

降低风险性子宫切除术后的健康相关生活质量:随机情境研究

Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.
PubMed 文献 · Gynecol Oncol · 2026-08-08

英国随机情境研究纳入1001名女性,采用EQ-5D评估40岁健康女性绝经前降低风险性子宫切除术(RRH)伴或不伴双侧输卵管卵巢切除术(BSO)在术后1个月和1年的健康效用值。结果显示RRH术后1年效用值最高,RRH-BSO术后1个月最低,各组间差异显著(p<0.001)。

要点

  • RRH术后1年效用值0.942,RRH-BSO术后1年0.841。
  • 术后1个月效用值低于1年,RRH-BSO最低为0.733。
  • 年龄、肥胖、月经过多、收入等因素与效用值评估相关。

核心结论

  • 绝经前RRH伴或不伴BSO在术后两个时间点的健康效用值经年龄性别匹配调整后可供咨询和卫生经济学评价使用。

研究设计与样本

  • 英国随机情境研究(PRESCORES part-2),纳入1001名女性随机分至4组,平均年龄53.6±11.4岁。

主要发现

  • RRH术后1年平均效用值0.942±0.072,RRH-BSO术后1年0.841±0.137,RRH术后1个月0.670±0.149,RRH-BSO术后1个月0.733±0.190,各组间差异显著(p<0.001)。
  • 年龄性别匹配调整后效用值分别为1.000(95%CI:1.00-1.00)、0.994(95%CI:0.97-1.00)、0.866(95%CI:0.84-0.90)、0.791(95%CI:0.77-0.81)。
  • 与情境评估相关的参与者因素包括年龄、肥胖、月经过多、较高收入和混合/其他族裔。

关键数值与推荐

  • RRH术后1年效用值0.942±0.072,调整后1.000(95%CI:1.00-1.00)。
  • RRH-BSO术后1年效用值0.841±0.137,调整后0.994(95%CI:0.97-1.00)。
  • RRH术后1个月效用值0.670±0.149,调整后0.866(95%CI:0.84-0.90)。
  • RRH-BSO术后1个月效用值0.733±0.190,调整后0.791(95%CI:0.77-0.81)。

临床怎么用

  • 这些效用值可用于对子宫内膜癌风险增高女性进行RRH咨询和共享决策。
  • 效用值可用于子宫内膜癌预防的卫生经济学评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk-reducing hysterectomy (RRH) is the most effective endometrial cancer preventive strategy. Understanding health-related quality-of-life using health-related utility-scores (HRUS) is essential for counselling, shared decision-making, and informing health-economic evaluations of endometrial cancer prevention. This study aimed to determine HRUS for premenopausal RRH, with and without bilateral salpingo-oophorectomy (BSO). METHODS: Preventing Endometrial-Cancers: Comparing Risk-Reducing Strategies (PRESCORES) (ISRCTN17432105) part-2 is a UK-based randomised vignette study. Following a robust development process, vignettes described four postoperative health-states for a 40-year-old otherwise-healthy woman: "RRH at 1-month", "RRH at 1-year", "RRH-BSO at 1-month", "RRH-BSO at 1-year". These were valued using EQ-5D by participants recruited from the UK general-population and HRUS calculated. Utilities were subsequently adjusted by age-and sex-matched general-population reference values. Association of variables was explored with ordinary-least-squares regression with non-parametric bootstrapping. FINDINGS: Overall, 1001 women were included and randomised to 1-of-4 groups. The mean-age(±SD) was 53.6 (±11.4) years. Mean(±SD) HRUS were 0.942 (±0.072) for "RRH at 1-year", 0.841 (±0.137) for "RRH-BSO at 1-year", 0.670 (±0.149) for "RRH at 1-month", and 0.733 (±0.190) for "RRH-BSO at 1-month", with significant difference between each group (p < 0.001). Adjusting for age-sex-matched population reference utilities, HRUS were 1.000(95% CI:1.00-1.00), 0.994(95% CI:0.97-1.00), 0.866(95% CI:0.84-0.90) and 0.791(95% CI:0.77-0.81), respectively. Participant factors associated with vignette valuations included age, obesity, heavy menstrual-bleeding, higher income and mixed/other ethnicity. CONCLUSION: This randomised study provides HRUS following premenopausal RRH with and without BSO at two postoperative time-points, with adjustment against the age-and sex-matched general reference-population. These values are of relevance for informing counselling of women at increased endometrial cancer-risk regarding RRH and for health-economic evaluations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Oxley S, Dibden A, Whenham T, et al. Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study. Gynecol Oncol. 2026. PMID: 42570385. doi:10.1016/j.ygyno.2026.07.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。